Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety"

被引：0
|
作者：
Yamamoto, Hiroyasu [1 ]
Nobori, Kiyoshi [2 ]
Matsuda, Yoshimi [2 ]
Hayashi, Yasuhiro [3 ]
Hayasaki, Takanori [3 ]
Akizawa, Tadao [4 ]
机构：
[1] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Tokyo, Japan
[2] Bayer Yakuhin Ltd, Res & Dev Japan, Osaka, Japan
[3] Bayer Yakuhin Ltd, Med Affairs & Pharmacovigilance, Osaka, Japan
[4] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2022年 / 52卷 / 12期
关键词：
D O I：
10.1159/000520156
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：977 / 978
页数：2
相关论文
共 50 条
  • [1] HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety
    Roger, Simon D.
    Coyne, Daniel W.
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 894 - 897
  • [2] Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
    Mahesh Kumar Teli
    G. K. Rajanikant
    Molecular Diversity, 2012, 16 : 193 - 202
  • [3] Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
    Teli, Mahesh Kumar
    Rajanikant, G. K.
    MOLECULAR DIVERSITY, 2012, 16 (01) : 193 - 202
  • [4] Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
    Francesco Locatelli
    Roberto Minutolo
    Luca De Nicola
    Lucia Del Vecchio
    Drugs, 2022, 82 : 1565 - 1589
  • [5] Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
    Locatelli, Francesco
    Minutolo, Roberto
    De Nicola, Luca
    Del Vecchio, Lucia
    DRUGS, 2022, 82 (16) : 1565 - 1589
  • [6] Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
    Yum, Soohwan
    Jeong, Seongkeun
    Kim, Dohoon
    Lee, Sunyoung
    Kim, Wooseong
    Yoo, Jin-Wook
    Kim, Jung-Ae
    Kwon, Oh Sang
    Kim, Dae-Duk
    Min, Do Sik
    Jung, Yunjin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [7] HIF-Prolyl Hydroxylase-Inhibitors - An interesting Alternative for Treating renal Anemia with Erythropoietin Analogues?
    Lutz, J.
    NEPHROLOGE, 2016, 11 (02): : 146 - 147
  • [8] HIF prolyl hydroxylase inhibitors for anemia
    Muchnik, Eugene
    Kaplan, Joshua
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (05) : 645 - 656
  • [9] Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)
    Flagg, Shannon C.
    Martin, Cristina B.
    Taabazuing, Cornelius Y.
    Holmes, Breanne E.
    Knapp, Michael J.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 113 : 25 - 30
  • [10] Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase
    Jeon, Hyunchu
    Kim, Heejung
    Choi, Daekyu
    Kim, Duksoo
    Park, Shi-Young
    Kim, Yung-Jin
    Kim, Young Mi
    Jung, Yunjin
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1676 - 1684
12345